Baxter Recalls Travasol Amino Acid Injection Due to Sterility Concerns
Baxter Healthcare is recalling 14,622 bags of Travasol Amino Acid Injection because leaking containers prevent assurance of sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an intravenous product, which poses a significant risk of serious injury or infection.
Plain-English summary
Baxter Healthcare Corp. is recalling 14,622 bags of Travasol (Amino Acid) Injection, 10%, 2000 ml, Pharmacy Bulk Package. The product is identified by Lot P302646 with an expiration date of 5/31/15. The recall was initiated because the drug product was found leaking from the container, which means the sterility of the product cannot be assured.
The affected product is a prescription drug intended for intravenous use. It is distributed nationwide. The specific NDC for the recalled package is 0338-0644-06.
Healthcare providers and pharmacies should stop using the affected product and contact Baxter Healthcare for further instructions. Patients who have received this product should consult their healthcare provider.
The recalled product
- Product
- TRAVASOL (LEUCINE, PHENYLALANINE, LYSINE HYDROCHLORIDE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, TYROSINE, SERINE)
- Brand
- TRAVASOL
- Manufacturer
- Baxter Healthcare Corp.
- Category
- Drug — Amino Acid Injection
- Hazard
- Affected units
- 14,622
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: P302646
- Exp 5/31/15
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Baxter Healthcare Corp.
See all →- HighBaxter Amia Automated Peritoneal Dialysis Set Recalled for Flow Issues
FDA (Devices) · 2017-09-20
- ModerateBaxter Recalls SIGMA Spectrum Infusion Pump Rear Case Assemblies
FDA (Devices) · 2016-12-07
- ModerateBaxter Recalls Sigma Spectrum Infusion Pumps Due to Speaker Failure Risk
FDA (Devices) · 2016-12-07
- ModerateBaxter SIGMA Spectrum Infusion Pump Recall for Speaker Failure
FDA (Devices) · 2016-12-07
- HighBaxter Recalls Revaclear MAX Dialyzers Due to Potential Particulate Matter
FDA (Devices) · 2016-11-16
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29